151 related articles for article (PubMed ID: 30829082)
1. An assessment of the survival impact of multimodal anesthesia/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis.
Cata JP; Nguyen LT; Ifeanyi-Pillette IC; Van Meter A; Dangler LA; Feng L; Owusu-Agyemang P
Int J Hyperthermia; 2019; 36(1):369-375. PubMed ID: 30829082
[TBL] [Abstract][Full Text] [Related]
2. Effect of opioid-free anesthesia on post-operative period in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched study.
Liet S; Logeay M; Besnier E; Selim J; Wood G; Tuech JJ; Coget J; Compère V; Occhiali E; Popoff B; Clavier T
Acta Chir Belg; 2024 Apr; 124(2):81-90. PubMed ID: 36970976
[TBL] [Abstract][Full Text] [Related]
3. Assessing the survival impact of perioperative opioid consumption in children and adolescents undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Owusu-Agyemang P; Hayes-Jordan A; Van Meter A; Williams UU; Zavala AM; Kapoor R; Popovich SM; Rebello E; Feng L; Cata JP
Paediatr Anaesth; 2017 Jun; 27(6):648-656. PubMed ID: 28419679
[TBL] [Abstract][Full Text] [Related]
4. Anesthesia and pain management of pediatric cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Suchar AM; Lane J; King AC; Hayes AA; Phelps JR
Paediatr Anaesth; 2023 Mar; 33(3):193-200. PubMed ID: 36052662
[TBL] [Abstract][Full Text] [Related]
5. Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study.
Lorimier G; Seegers V; Coudert M; Dupoiron D; Thibaudeau E; Pouplin L; Lebrec N; Dubois PY; Dumont F; Guérin-Meyer V; Capitain O; Campone M; Wernert R
Eur J Surg Oncol; 2018 Nov; 44(11):1824-1831. PubMed ID: 30213715
[TBL] [Abstract][Full Text] [Related]
6. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
7. Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
van Eden WJ; Kok NF; Jóźwiak K; Lahaye ML; Beets GL; van Leerdam ME; Boot H; Aalbers AG
Dis Colon Rectum; 2017 May; 60(5):477-487. PubMed ID: 28383447
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of peritoneal cancer index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience.
Brandl A; Weiss S; von Winterfeld M; Krannich A; Feist M; Pratschke J; Raue W; Rau B
Int J Hyperthermia; 2018 Aug; 34(5):512-517. PubMed ID: 28679331
[TBL] [Abstract][Full Text] [Related]
9. A Dedicated Acute Pain Service Is Associated With Reduced Postoperative Opioid Requirements in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
Said ET; Sztain JF; Abramson WB; Meineke MN; Furnish TJ; Schmidt UH; Manecke GR; Gabriel RA
Anesth Analg; 2018 Oct; 127(4):1044-1050. PubMed ID: 29596098
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J
Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the survival impact of dexmedetomidine in children undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Owusu-Agyemang P; Cata JP; Kapoor R; Zavala AM; Williams UU; Van Meter A; Tsai JY; Zhang WH; Feng L; Hayes-Jordan A
Int J Hyperthermia; 2018; 35(1):435-440. PubMed ID: 30303410
[TBL] [Abstract][Full Text] [Related]
12. Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis.
Wang Y; Ren F; Chen P; Liu S; Song Z; Ma X
Eur J Surg Oncol; 2019 Mar; 45(3):301-309. PubMed ID: 30786961
[TBL] [Abstract][Full Text] [Related]
13. Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience.
Gupta N; Asif S; Gandhi J; Rajpurohit S; Singh S
Indian J Gastroenterol; 2017 Mar; 36(2):126-130. PubMed ID: 28393331
[TBL] [Abstract][Full Text] [Related]
14. Volume-Time Index Is Not an Indicator of Outcome for Patients Undergoing CRS/HIPEC for Treatment of High-Grade Appendiceal Carcinomatosis.
Dotta DM; Lansom JD; Fisher OM; Fracs NAA; Liauw W; Morris DL
Anticancer Res; 2019 Dec; 39(12):6813-6817. PubMed ID: 31810947
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
16. Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis.
Nunez MF; Sardi A; Jimenez W; Nieroda C; Sittig M; MacDonald R; Aydin N; Milovanov V; Gushchin V
Ann Surg Oncol; 2015 Apr; 22(4):1267-73. PubMed ID: 25319578
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases.
Tonello M; Ortega-Perez G; Alonso-Casado O; Torres-Mesa P; Guiñez G; Gonzalez-Moreno S
Clin Transl Oncol; 2018 Oct; 20(10):1268-1273. PubMed ID: 29667123
[TBL] [Abstract][Full Text] [Related]
18. Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Randle RW; Griffith KF; Fino NF; Swett KR; Stewart JH; Shen P; Levine EA; Votanopoulos KI
J Surg Res; 2015 Jun; 196(2):229-34. PubMed ID: 25881787
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Wong EYT; Tan GHC; Chia CSL; Kumar M; Soo KC; Teo MCC
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e193-e202. PubMed ID: 28695617
[TBL] [Abstract][Full Text] [Related]
20. More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Solomon D; DeNicola NL; Feferman Y; Bekhor E; Reppucci ML; Feingold D; Aycart SN; Magge DR; Golas BJ; Labow DM; Sarpel U
Ann Surg Oncol; 2019 Mar; 26(3):845-851. PubMed ID: 30643994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
